Sage Therapeutics, Inc. (SAGE)

Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	99.63	70.99	162.7	294.23	1,661	126.71
Short-Term Investments	469.53	682.19	1,110	1,448	438.47	881.69
Cash & Short-Term Investments	569.15	753.18	1,272	1,742	2,100	1,008
Cash Growth	-35.03%	-40.81%	-26.96%	-17.02%	108.21%	9.28%
Receivables	18.07	84.41	15.16	19.61	-	-
Inventory	-	1.5	1.7	1.4	-	-
Prepaid Expenses	16.43	28.93	47.63	37.34	22.82	26.7
Restricted Cash	1.33	1.33	-	-	-	-
Total Current Assets	604.99	869.35	1,337	1,801	2,122	1,035
Property, Plant & Equipment	12.27	6.38	13.43	19.13	31.82	42.9
Other Long-Term Assets	5.18	6.55	6.04	5.52	5.06	6.16
Total Assets	622.43	882.28	1,356	1,825	2,159	1,084
Accounts Payable	7.13	10.32	18.95	10.45	3.69	15.27
Accrued Expenses	53.05	56.68	72.67	67.28	54.85	86.62
Current Portion of Leases	0.08	5.17	7.64	7.47	8.66	10.24
Other Current Liabilities	0.15	10.59	-	-	-	-
Total Current Liabilities	60.41	82.75	99.26	85.19	67.2	112.13
Long-Term Leases	10.19	-	4.49	10.96	19.44	26.85
Other Long-Term Liabilities	-	-	0.1	0.1	0.27	0.52
Total Liabilities	70.6	82.75	103.85	96.26	86.91	139.5
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,426	3,370	3,291	3,227	3,110	2,587
Retained Earnings	-2,875	-2,570	-2,028	-1,495	-1,037	-1,644
Treasury Stock	-0.4	-0.4	-0.4	-0.4	-0.4	-0.4
Comprehensive Income & Other	0.9	-0.81	-10.21	-2.66	0.42	1.3
Total Common Equity	551.84	799.53	1,253	1,729	2,072	944.66
Shareholders' Equity	551.84	799.53	1,253	1,729	2,072	944.66
Total Liabilities & Equity	622.43	882.28	1,356	1,825	2,159	1,084
Total Debt	10.27	5.17	12.13	18.43	28.1	37.09
Net Cash (Debt)	558.88	748.02	1,260	1,724	2,071	971.3
Net Cash Growth	-35.69%	-40.65%	-26.89%	-16.78%	113.27%	5.26%
Net Cash Per Share	9.25	12.50	21.25	29.38	39.08	19.11
Filing Date Shares Outstanding	61.17	60.11	59.72	59.05	58.38	51.91
Total Common Shares Outstanding	61.17	60.04	59.51	58.94	58.31	51.88
Working Capital	544.58	786.6	1,238	1,715	2,055	922.97
Book Value Per Share	9.02	13.32	21.05	29.34	35.54	18.21
Tangible Book Value	551.84	799.53	1,253	1,729	2,072	944.66
Tangible Book Value Per Share	9.02	13.32	21.05	29.34	35.54	18.21
Machinery	-	3.9	3.49	2.6	4.62	4.66
Leasehold Improvements	-	5.51	5.51	5.39	9.22	8.97

Source: S&P Capital IQ. Standard template. Financial Sources.